Company: GEHC
Filing Date: 2025-12-02
Form Type: 424B2
Source: 0001193125-25-305442
Chunk: 60

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-12-02
Form: 424B2
Chunk 60
---
 expectation or belief will result or be achieved or accomplished. Any forward-looking statement speaks only as of the date on which it is made. Factors that could cause our actual results to differ materially from those described in our forward-looking statements include, but are not limited to:

| • |     | operating in highly competitive markets; |

| • |     | our ability to successfully complete strategic transactions; |

| • |     | the actions or inactions of third parties with whom we partner and the various collaboration, licensing, and 
 other partnerships and alliances we have with third parties;                                                 |

| • |     | demand for our products, services, or solutions and factors that affect that demand; |

| • |     | management of our supply chain and our ability to cost-effectively secure the materials we need to operate our 
 business;                                                                                                      |

| • |     | disruptions in our operations; |

| • |     | changes in third-party and government reimbursement processes, rates, contractual relationships, and mix of 
 public and private payers, including related to government shutdowns;                                       |

| • |     | our ability to attract and/or retain key personnel and qualified employees; |

| • |     | global geopolitical and economic instability, including as a result of the conflict between Ukraine and Russia, 
 the conflict in Israel and surrounding areas, and the actions in the Red Sea region;                            |

| • |     | public health crises, epidemics, and pandemics and their effects on our business; |

| • |     | maintenance and protection of our intellectual property rights, as well as maintenance of successful research and 
 development efforts with respect to commercially successful products and technologies;                            |

| • |     | the impact of potential information technology, cybersecurity, or data security breaches; |

| • |     | compliance with the various legal, regulatory, tax, privacy, and other laws to which we are subject, such as the                                              
 Foreign Corrupt Practices Act and similar anti-corruption and anti-bribery laws globally, and related changes, claims, inquiries, investigations, or actions; |

| • |     | our ability to control increases in healthcare costs and any subsequent effect on demand for our products, 
 services, or solutions;                                                                                    |

iii

| • |     | the impacts related to our increasing focus on and investment in cloud, edge, artificial intelligence, and 
 software offerings;                                                                                        |

| • |     | the impact of potential product liability claims; |

| • |     | environmental, social, and governance matters